“…Samples were treated anonymously. HUVECs were transduced with a vector containing the RFP gene under the control of the EF1a promoter following a procedure similar to the one previously described [24]. RFP-labeled HUVECs were cultured in Iscove's Modified Dulbecco's Medium (IMDM, Gibco, Paisley, Scotland, UK) containing 20% fetal bovine serum (FBS, GE Healthcare, Pasching, Austria), 20 μg ml −1 endothelial cell growth supplement, 90 μg ml −1 heparin (ECGS/H 0.4% (v/v); PromoCell, Heidelberg, Germany) and 10% endothelial cell growth medium-2 (EGM-2 MV, Lonza, Walkersville, MD, USA), in a controlled atmosphere (5% CO 2 , 95% relative humidity (RH), 37 °C-incubator (Binder, Germany)).…”